Stay updated on Pembrolizumab for EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for EGFR+ NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the page removed the government funding lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T02:19:58.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, informing users that information may not be up to date and transactions may not be processed, and that the NIH Clinical Center is open; the site version was updated to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-03T23:08:20.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows the glossary and updates several metadata labels (e.g., Last Update Submitted that Met QC Criteria) with a new revision label v3.4.0, while some legacy labels and capitalization were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T21:07:00.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.1%
    Check dated 2026-01-20T15:32:20.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a new Locations section with California as a listed site and updated the revision from v3.3.2 to v3.3.3. The old California Locations link and the HHS Vulnerability Disclosure have been removed.
    Difference
    0.2%
    Check dated 2025-12-23T00:27:54.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page now displays a revision label 'Revision: v3.3.2' replacing the previous 'Revision: v3.3.1'.
    Difference
    0.1%
    Check dated 2025-12-01T15:41:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for EGFR+ NSCLC Clinical Trial page.